Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions.
about
Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.Current research on opioid receptor function.Isoflurane preconditioning increases endothelial cell tolerance to in-vitro simulated ischaemia.Morphine preconditioning reduces lipopolysaccharide and interferon-gamma-induced mouse microglial cell injury via delta 1 opioid receptor activation.Isoflurane induces a postconditioning effect on bovine pulmonary arterial endothelial cells exposed to oxygen-glucose deprivation.Postconditioning with isoflurane reduced ischemia-induced brain injury in rats.Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats.Use of opioids in asphyxiated term neonates: effects on neuroimaging and clinical outcome.Survival rate in patients after sudden cardiac arrest at the university hospital of northern Norway treated with or without opioids: A retrospective evaluationAmelioration of rCBF and PbtO2 following TBI at high altitude by hyperbaric oxygen pre-conditioning.Ionic storm in hypoxic/ischemic stress: can opioid receptors subside it?The beneficial effect of melatonin in brain endothelial cells against oxygen-glucose deprivation followed by reperfusion-induced injuryPharmacologic preconditioning: translating the promiseδ-opioid receptor activation and microRNA expression of the rat cortex in hypoxiaA novel insight into neuroprotection against hypoxic/ischemic stress.delta-Opioid receptors protect from anoxic disruption of Na+ homeostasis via Na+ channel regulationStem cell transplantation in an in vitro simulated ischemia/reperfusion model.Pharmacological neuroprotection during cardiac surgery.Activation of DOR attenuates anoxic K+ derangement via inhibition of Na+ entry in mouse cortex.δ-Opioid receptor activation rescues the functional TrkB receptor and protects the brain from ischemia-reperfusion injury in the ratDelta opioid receptor and its peptide: a receptor-ligand neuroprotectionNa+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortexLigand-gated purinergic receptors regulate HIV-1 Tat and morphine related neurotoxicity in primary mouse striatal neuron-glia co-cultures.Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.Neuroprotective potential of biphalin, multireceptor opioid peptide, against excitotoxic injury in hippocampal organotypic culture.Morphine pre- and post-conditioning exacerbates apoptosis in rat hippocampus cells in a model of homocysteine-induced oxidative stress.Opioid receptor-independent protection of ischemic rat hepatocytes by morphine.Anisomycin protects cortical neurons from prolonged hypoxia with differential regulation of p38 and ERK.Cortical delta-opioid receptors potentiate K+ homeostasis during anoxia and oxygen-glucose deprivation.delta-, but not mu-, opioid receptor stabilizes K(+) homeostasis by reducing Ca(2+) influx in the cortex during acute hypoxia.Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders.Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit.
P2860
Q26866231-1B01D029-64AC-4A99-835D-04533EFE27F9Q27693220-52BFF3FB-CB2F-478E-BA8A-7A32220DCBCBQ30429156-C5794EC0-B13D-4219-8F43-BAFE75C2A363Q30432409-64D6FDCC-518D-45B2-9AD7-494E3DF0A0ECQ30435292-84705499-7EFA-420D-B5B6-1A390BD1C69CQ30439887-A62BC8E2-9D75-4D5A-894B-C2FEC7CE967FQ30441793-F1C85AA8-E98A-4090-BABD-690F289239B5Q30985263-D1DB2AEF-5CD1-4A26-A0EB-94EF17EB5A58Q33163247-4A4EDDE0-F4A7-4CEE-A6A6-7C836A0C8218Q33531564-319AD2BD-7B73-4733-8E40-B0CDE864064AQ33746364-AC1EF3D5-F395-4D1E-94DA-449BAEE10BB2Q34003451-FD3820CD-C805-4722-BF1D-0A4EF0567FB1Q34440453-5980BFB1-B446-41EB-9486-E884B4DEC175Q34525319-897590D3-9798-429D-9C01-C8509ABD93F1Q34554858-03356BB4-BF1F-4D2A-BD9F-9466EB37433BQ34700747-A23F9E6B-7CCF-440C-86A6-B29D29F6557EQ35841592-01BEFF03-9FE9-4468-B99E-7D676E907E7AQ36771142-D1F26CA0-07E4-400B-936A-1AF936062D5CQ36839108-92B0FEC3-6287-4B59-8653-051141D60469Q36976448-3AA148BA-5D19-447A-9EAC-EE65B0966F50Q37225038-806B2782-0923-42D0-BF54-F220ABE94548Q37247084-5E4F6566-863A-4858-8347-00F7FEF39A80Q37646749-B635AE28-F218-4F83-B70A-50BB5033EBBFQ38046756-65B8F96A-E924-4226-B75F-F8252179C04BQ38593348-4A42289E-B1FB-4AE3-B450-088F3E66F187Q41530211-16E57B78-8F55-4A27-9ADD-108898D58FABQ42129692-D397C203-7A4D-4B2B-80F3-BAF159C2AD1AQ42138360-EA0B1E6B-EF3B-422B-B352-AFAF7FEE45E5Q44330911-B5147FD2-11AD-464D-9475-B60FB30F43BAQ44334405-74692C8C-8B37-4976-A701-7065E66BD840Q44344083-FE131B54-5103-4B04-B4E1-02BE917EC0C4Q48629661-455F84E8-8A13-4C36-B572-C5078261C0D1
P2860
Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Morphine preconditions Purkinj ...... chemia-reperfusion conditions.
@ast
Morphine preconditions Purkinj ...... chemia-reperfusion conditions.
@en
type
label
Morphine preconditions Purkinj ...... chemia-reperfusion conditions.
@ast
Morphine preconditions Purkinj ...... chemia-reperfusion conditions.
@en
prefLabel
Morphine preconditions Purkinj ...... chemia-reperfusion conditions.
@ast
Morphine preconditions Purkinj ...... chemia-reperfusion conditions.
@en
P2093
P1433
P1476
Morphine preconditions Purkinj ...... chemia-reperfusion conditions.
@en
P2093
Shuqiu Zheng
Young Jin Lim
P304
P356
10.1097/00000542-200403000-00015
P407
P577
2004-03-01T00:00:00Z